Proquility Private Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.66M Buy
3,216
+2,789
+653% +$2.32M 0.82% 44
2024
Q4
$330K Sell
427
-1,238
-74% -$1.03M 0.11% 86
2024
Q3
$1.48M Buy
+1,665
New +$1.5M 0.47% 60
2023
Q2
Sell
-2,660
Closed -$913K 89
2023
Q1
$913K Sell
2,660
-817
-23% -$276K 0.36% 68
2022
Q4
$1.27M Buy
3,477
+27
+0.8% +$9.57K 0.52% 54
2022
Q3
$1.12M Sell
3,450
-168
-5% -$53.2K 0.51% 58
2022
Q2
$1.17M Sell
3,618
-24
-0.7% -$7.2K 0.5% 60
2022
Q1
$1.06M Sell
3,642
-207
-5% -$53.3K 0.44% 62
2021
Q4
$922K Sell
3,849
-593
-13% -$150K 0.32% 73
2021
Q3
$1.03M Buy
4,442
+85
+2% +$21K 0.39% 64
2021
Q2
$1M Buy
4,357
+81
+2% +$16.3K 0.38% 65
2021
Q1
$799K Sell
4,276
-2,402
-36% -$470K 0.32% 73
2020
Q4
$1.13M Buy
+6,678
New +$997K 0.52% 51

Other funds holding LLY

Proquility Private Wealth Partners's LLY Position: Q1 2025 in Review

Proquility Private Wealth Partners increased its Eli Lilly (LLY) stake by 653% in Q1 2025, buying an estimated $2.32M and bringing the position to 3,216 shares worth $2.66M. The position accounts for 0.82% of the portfolio, ranked #44.

Proquility Private Wealth Partners first reported a position in LLY in Q4 2020 and has held it in 13 quarters since. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Proquility Private Wealth Partners held 3,216 shares of Eli Lilly worth $2.66M as of Q1 2025.
  • Proquility Private Wealth Partners bought 2,789 Eli Lilly shares in Q1 2025, an estimated $2.32M.
  • Eli Lilly made up 0.82% of Proquility Private Wealth Partners's portfolio in Q1 2025, its #44 holding.
  • Proquility Private Wealth Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 13 quarters since.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Proquility Private Wealth Partners's 13F filing for Q1 2025, filed 15 May 2025.